CN1737136A - Production method of animal use recombinant interferon - Google Patents

Production method of animal use recombinant interferon Download PDF

Info

Publication number
CN1737136A
CN1737136A CN 200510047204 CN200510047204A CN1737136A CN 1737136 A CN1737136 A CN 1737136A CN 200510047204 CN200510047204 CN 200510047204 CN 200510047204 A CN200510047204 A CN 200510047204A CN 1737136 A CN1737136 A CN 1737136A
Authority
CN
China
Prior art keywords
interferon
rabbit
production method
recombinant interferon
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510047204
Other languages
Chinese (zh)
Inventor
江国托
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DALIAN SANYI ANIMAL MEDICINE Co Ltd
Original Assignee
DALIAN SANYI ANIMAL MEDICINE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DALIAN SANYI ANIMAL MEDICINE Co Ltd filed Critical DALIAN SANYI ANIMAL MEDICINE Co Ltd
Priority to CN 200510047204 priority Critical patent/CN1737136A/en
Publication of CN1737136A publication Critical patent/CN1737136A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a production method of animal use recombinant interferon, wherein the raw recombinant interferon is subject to condensation, separating, purifying, formulation and filter membrane degerming. The method has the advantages of low cost of production, prevention of potential exogenesis viruses and other pathogenic microorganisms, and improved product purity.

Description

The production method of animal use recombinant interferon
Technical field:
The present invention relates to a kind of production method of Interferon, rabbit, the production method of especially a kind of purity height, active strong animal use recombinant interferon.
Background technology:
Interferon, rabbit is the class protein with antiviral, antitumor and immunoloregulation function that multiple inductor (as virus, bacterium and other macromole etc.) inducing cell produces.The production method of Interferon, rabbit was to be that raw material is made with animal blood in the past, cost height not only, and also have potential danger of carrying exogenous virus and other pathogenic micro-organisms in the product.In order to overcome the disadvantage that conventional production methods is brought, people have adopted genetically engineered production recombinant interferon, especially with the gene clone of animal interferon in expression vector pBV220, and be transformed in the bacillus coli DH 5 alpha, the positive colony of screening produced bacterial classification with temperature-induced expression and make the production method of recombinant interferon more advanced, its exogenous gene expression amount can reach the 20%-30% of total protein.Compare production cost with blood product and reduce greatly, can descend about 10,000 times, also avoided potential danger of carrying exogenous virus and other pathogenic micro-organisms simultaneously fully.But the activeconstituents of the recombinant interferon that existing genetic engineering process for preparing is produced all exists with the form of inclusion body, reduced the product activity effect, and product purity is not high, contains other foreign protein.
Summary of the invention:
The present invention is in order to solve the active low technical problem of existing in prior technology, and the production method of a kind of purity height, active strong animal use recombinant interferon is provided.
Technical solution of the present invention is: a kind of production method of animal use recombinant interferon, with the gene clone of animal interferon in expression vector pBV220, and be transformed in the bacillus coli DH 5 alpha, the positive colony of screening is produced bacterial classification and made rough Interferon, rabbit with temperature-induced expression, it is characterized in that also comprising the steps:
A. be that the hollow cellulose ultra-fine filter of 10000 relative molecular weights concentrates with rough Interferon, rabbit through the amount of damming;
B. spissated interferon solution is separated through Sephadex G50, series of strata 2cm*100cm with 20mmol/l, pH7.0 phosphate buffered saline buffer balance, separates with same buffer solution elution behind the upper prop earlier, checks through SDS-PAGE, collects the Interferon, rabbit part;
C. with the Interferon, rabbit collected again through the DE-52 column purification, behind the upper prop with contain 0.05,0.1, the 20mM/L of 0.15mol/LnaCl, pH7.0 phosphate buffer soln wash respectively, collects the elutriant that contains Interferon, rabbit, work in-process;
D. work in-process being made the content of resultant interference element with the dilution of pyrogen-free physiological saline is 1%~2%, uses 0.22 μ m aperture filter membrane degerming then, packing.
The present invention is on the basis of existing technology, to rough recombinant interferon concentrate, separation, purification, preparation and filter membrane degerming.The recombinant interferon of being produced except that have production cost low, avoid the potential advantage of carrying exogenous virus and other pathogenic micro-organisms, the whole process protein recovery is 25% simultaneously, do not contain foreign protein in the product, it is qualified to have improved the purity of product and DNA and thermal source matter content; Changed the existing way of activeconstituents, strengthened product activity, made the product activity composition really bring into play active function.
Embodiment:
Embodiment:
With the rough recombinant interferon of prior art for preparing, specific practice is as follows:
1. according to the various animal interferon gene orders of delivering on the Genbank, respectively the chicken splenic lymphocyte that stimulates from ConA, from the duck splenic lymphocyte of mitogenstimulated, extract geneome RNA, from pig liver and dog blood, extract genomic dna;
2. according to the Interferon, rabbit sequence of delivering on the Genbank, adopt a pair of oligonucleotide primer of Oligo software design, carry out the molecular modification of restriction enzyme at 5 of upstream and downstream primer ' end;
3. if the genome that extracts is RNA then adopts RT-PCR amplification interferon gene, if the genome that extracts is that DNA then adopts the pcr amplification interferon gene;
4.RT-PCR or the goal gene that pcr amplification obtains is through sequential analysis;
5. interferon gene is cloned among the expression vector pBV220, and is transformed in the bacillus coli DH 5 alpha, the positive colony temperature-induced expression of screening;
6.SDS-PAGE, Western Blot identifies expression product;
7. the cryopreservation of the Interferon, rabbit of stably express being reserved seed for planting is standby in the original strain storehouse;
8. spread out of from the original strain storehouse, freeze-drying is preserved after enlarging, or is spread out of with strain library by the previous generation manufacturing, enlarges the back freeze-drying and preserves as the manufacturing strain library.
9. spread out of bacterial classification from making for production usefulness with strain library, through gramstaining, electron microscopic examination, biochemical reaction, plasmid identify, the satisfactory bacterial classification of expression amount is as producing bacterial classification.
10. select for the bacterial classification (seed liquor) of doing fermentation usefulness from producing bacterial classification, seed liquor is done according to actual needs to expand and is gone down to posterity, as the seed liquor of jar cultivation;
11. fermentation culture;
12. collect thalline with centrifuging, thalline can be preserved 1 year down at-20 ℃;
13. with proper method cracking thalline such as Guanidinium hydrochloride or N,O-Diacetylmuramidase or high-pressure homogenization pumps;
14. cellular lysate is after centrifugal gained supernatant liquor is rough Interferon, rabbit.
Carry out by the following method again:
A. be that the hollow cellulose ultra-fine filter of 10000 relative molecular weights concentrates with rough Interferon, rabbit through the amount of damming;
B. spissated interferon solution is separated through Sephadex G50, series of strata 2cm*100cm with 20mmol/l, pH7.0 phosphate buffered saline buffer balance, separates with same buffer solution elution behind the upper prop earlier, checks through SDS-PAGE, collects the Interferon, rabbit part;
C. with the Interferon, rabbit collected again through the DE-52 column purification, behind the upper prop with contain 0.05,0.1, the 20mM/L of 0.15mol/LNaCl, pH7.0 phosphate buffer soln wash respectively, collects the elutriant that contains Interferon, rabbit, work in-process;
D. work in-process being made the resultant interference cellulose content with the dilution of pyrogen-free physiological saline is 1%~2%, uses 0.22 μ m aperture filter membrane degerming then, packing.
The work in-process calibrating:
Every batch of calibrating such as work in-process sampling carrying out titration, protein content, specific activity, high-efficient liquid phase color spectral purity, UV spectrum absorption, sterility test, pyrogen test, the result meets the requirements.
The finished product calibrating:
Finished product is through checks such as outward appearance, pH value, titration, telling test, sterility test, pyrogen test, proof tests.The whole process protein recovery is 25%, and product does not contain foreign protein, and DNA and thermal source matter content are qualified, and the result meets the requirements.

Claims (1)

1. the production method of an animal use recombinant interferon, with the gene clone of animal interferon in expression vector pBV220, and be transformed in the bacillus coli DH 5 alpha, the positive colony of screening is produced bacterial classification and made rough Interferon, rabbit with temperature-induced expression, it is characterized in that also comprising the steps:
A. be that the hollow cellulose ultra-fine filter of 10000 relative molecular weights concentrates with rough Interferon, rabbit through the amount of damming;
B. spissated interferon solution is separated through Sephadex G50, series of strata 2cm*100cm with 20mmol/l, pH7.0 phosphate buffered saline buffer balance, separates with same buffer solution elution behind the upper prop earlier, checks through SDS-PAGE, collects the Interferon, rabbit part;
C. with the Interferon, rabbit collected again through the DE-52 column purification, behind the upper prop with contain 0.05,0.1, the 20mM/L of 0.15mol/LNaCl, pH7.0 phosphate buffer soln wash respectively, collects the elutriant that contains Interferon, rabbit, work in-process;
D. work in-process are diluted with pyrogen-free physiological saline, making the resultant interference cellulose content is 1%~2%, uses 0.22 μ m aperture filter membrane degerming then, packing.
CN 200510047204 2005-09-12 2005-09-12 Production method of animal use recombinant interferon Pending CN1737136A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510047204 CN1737136A (en) 2005-09-12 2005-09-12 Production method of animal use recombinant interferon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510047204 CN1737136A (en) 2005-09-12 2005-09-12 Production method of animal use recombinant interferon

Publications (1)

Publication Number Publication Date
CN1737136A true CN1737136A (en) 2006-02-22

Family

ID=36080083

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510047204 Pending CN1737136A (en) 2005-09-12 2005-09-12 Production method of animal use recombinant interferon

Country Status (1)

Country Link
CN (1) CN1737136A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106520815A (en) * 2016-12-30 2017-03-22 大连三仪动物药品有限公司 Construction of recombinant chicken alpha interferon temperature-control expression vector
CN106749609A (en) * 2016-12-30 2017-05-31 大连三仪动物药品有限公司 A kind of ChIFN-alpha and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106520815A (en) * 2016-12-30 2017-03-22 大连三仪动物药品有限公司 Construction of recombinant chicken alpha interferon temperature-control expression vector
CN106749609A (en) * 2016-12-30 2017-05-31 大连三仪动物药品有限公司 A kind of ChIFN-alpha and preparation method thereof
CN106749609B (en) * 2016-12-30 2021-07-02 大连三仪动物药品有限公司 Chicken alpha interferon and preparation method thereof

Similar Documents

Publication Publication Date Title
CN113307848B (en) Cyclic color-silk-valyl-isoleucyl-leucinyl peptide with antifungal and free radical scavenging activities and preparation method thereof
CN109750054B (en) Mycoplasma bovis protein gene MbovGdpp and application thereof
US20210400965A1 (en) Novel Use of Prodigiosin in Resisting Potyvirus
CN1159447C (en) Microbe fermenting process of producing perfume phenylethanol
CN111777676B (en) Method for dissociative adsorption and concentration of recombinant interleukin-2 renaturation solution
CN104946552A (en) Gene engineering strain capable of safely and efficiently producing Phenazino-1-carboxylic acid and application thereof
CN1737136A (en) Production method of animal use recombinant interferon
Kumar et al. Cultural, morphological and molecular characterization of vinca alkaloids producing endophytic fungus Fusarium solani isolated from Catharanthus roseus
CN1177925C (en) Fermenting culture process of produicng Cordyceps extract
CN1766105A (en) Method for producing recombinant interleukin for animal
RU2230325C2 (en) Method for preparing purified preparation of botulinic toxin type a
CN113817757A (en) Recombinant yeast engineering strain for producing cherry glycoside and application
CN1240706C (en) Process for producing super critical extracting caterpillar fungus deoxynucleoside
CN1058992C (en) Recombinative human thrombocytopoietic factor and production thereof
CN1139546C (en) Biological flocculant prepared with Nocardia bacteria
CN1208467C (en) High-germanium ganoderic polysaccharide and ganoderic acid extraction method
CN1432578A (en) Recombinant protein A gene and prepn and application of its expression product
CN110724721B (en) Preparation method of antifungal peptide of meiyu processing byproduct
TW201838637A (en) Anti-inflammatory application of the extract from ophiocordyceps sinensis mycelium and production process thereof
Su et al. Candida tropicalis sp. Nov., a novel, zinc-enriched yeast species found in China
CN1080310C (en) Antibiotic wap-8294A, method for preparing the same and antibactercal composition
Boromenskyi et al. THE CONTENTS OF GANODERIC ACIDS IN MYCELIUM OF DIFFERENT GANODERMA SPECIES (GANODERMATACEAE) OBTAINED BY DIFFERENT METHODS OF CULTIVATION.
Kumari et al. Future of Scarlet Caterpillar Club Fungus: A Review on Molecular Strategies for Cordycepin Enhancement
CN1456662A (en) Barm expressing system of plasminogen and purifying process
CN118185775A (en) Preparation method and application of fungal immunomodulatory protein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication